Company intelligence / Profile preview

Septalyst Lifesciences

Thane, Maharashtra, Indiaseptalyst.com ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Septalyst Lifesciences is a Mumbai-based super-specialty pharmaceutical company established in 2010. It is recognized among the top five companies in Indian nephrology and is a leading player in the CNS segment. The company has developed several branded products for chronic kidney disease, renal transplantation, neuropsychiatric conditions, and critical care. Its R&D efforts have resulted in patented products like Kobacar for stroke patients and market-leading brands such as Synprotik for renal nutrition. The company operates with over 350 employees across India.

Therapeutic areas: NeurologyOtherPsychiatryNephrology
Modalities: Small molecules (based on product types such as tablets, capsules, injections)
Industry: Biotech

Drug pipeline

39 assets

KOBACAR

Unknown

38 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Septalyst Lifesciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septalyst Lifesciences.

Explore the full profile